Paloma Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-4,615
Closed -$598K – 1554
2022
Q1
$598K Sell
4,615
-3,949
-46% -$569K 0.02% 658
2021
Q4
$1.54M Buy
8,564
+8,286
+2,981% +$1.44M 0.02% 535
2021
Q3
$41K Buy
+278
New +$42.6K ﹤0.01% 986
2021
Q2
– Sell
-18,045
Closed -$2.34M – 2130
2021
Q1
$2.34M Buy
+18,045
New +$2.31M 0.05% 357
2018
Q3
– Sell
-5,989
Closed -$314K – 1835
2018
Q2
$314K Buy
5,989
+1,222
+26% +$57.5K 0.01% 1254
2018
Q1
$207K Buy
+4,767
New +$219K ﹤0.01% 1788
2016
Q2
– Sell
-7,200
Closed -$201K – 2282
2016
Q1
$201K Sell
7,200
-4,734
-40% -$130K ﹤0.01% 1694
2015
Q4
$371K Buy
+11,934
New +$352K 0.01% 1215
2015
Q3
– Sell
-6,000
Closed -$227K – 1819
2015
Q2
$227K Buy
+6,000
New +$219K ﹤0.01% 1483
2015
Q1
– Sell
-14,653
Closed -$485K – 1364
2014
Q4
$485K Buy
+14,653
New +$453K 0.02% 691

Other funds holding OMCL

Paloma Partners's OMCL Position: Q2 2022 in Review

Paloma Partners sold out of Omnicell (OMCL) in Q2 2022, closing a stake of 4,615 shares — an estimated $598K sold.

Paloma Partners first reported a position in OMCL in Q4 2014 and held it in 10 quarters. The position peaked at $2.34M in Q1 2021. 385 funds tracked by Wall St. Rank hold OMCL as of Q2 2022.

  • Paloma Partners reported no remaining Omnicell position as of Q2 2022 after selling out during the quarter.
  • Paloma Partners sold 4,615 Omnicell shares in Q2 2022, an estimated $598K.
  • Paloma Partners first reported a position in Omnicell in Q4 2014 and held it in 10 quarters.
  • Paloma Partners's Omnicell position peaked at $2.34M in Q1 2021.
  • 385 funds tracked by Wall St. Rank held Omnicell as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.